Ascorbic acid (vitamin C)

Generic name
Ascorbic acid (vitamin C)
Brand name
ATC Code
A11GA01
Compare …

Ascorbic acid (vitamin C)

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Deficiency
  • Oral
    • 1 month up to 18 years
      • 500 mg/day in 2 doses.
  • Intravenous
    • 1 month up to 18 years
      • 100 - 500 mg/day in 2 - 3 doses.
Prophylaxis
  • Oral
    • 1 month up to 18 years
      • 50 mg/day in 1 dose

Renal impaiment in children > 3 months

GFR ≥10 ml/min/1.73m2: Dose adjustment not required.

GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications in children

Do not administer injection fluid in premature infants.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

References

  1. Rademaker C.M.A. et al, Geneesmiddelen-Formularium voor Kinderen, 2007
  2. Ratiopharm Nederland BV, SPC ascorbinezuur (RVG 52396), www.cbg-meb.nl, Geraadpleegd 20 okt 2010, http://db.cbg-meb.nl/IB-teksten/h52396.pdf
  3. Pharmachemie BV, SPC ascorbinezuur (RVG 50876), www.cbg-meb.nl, Geraadpleegd 20 okt 2010, http://db.cbg-meb.nl/IB-teksten/h50876.pdf

Changes

Therapeutic Drug Monitoring


Overdose